 Shares of Myovant Sciences Ltd. MYOV, 2.34 shot up 27.2 in premarket trading Monday toward an 11-month high, after the biopharmaceutical company confirmed over the weekend that it received an unsolicited buyout bid from Sumitovant Biopharma Ltd. 